# Aclidinium: UK patient leaflet, explained

Source: patient information leaflet for Eklira Genuair 322 micrograms Inhalation Powder (licence PLPI568300161), approved by the MHRA. Leaflet dated 2026-11-06. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/3854e6b14144940a892e521d34b1100c313e1cc3

Canonical page: https://pestle.health/uk/aclidinium

## What is aclidinium for?
Eklira Genuair is a dry powder inhaler containing a bronchodilator, which relaxes the airways and helps keep them open. It is used to relieve the symptoms of COPD (chronic obstructive pulmonary disease), a serious, long-term lung disease that causes breathing difficulties, and to reduce flare-ups.

## Key facts
- It is a maintenance treatment for COPD and should not be used to treat a sudden attack of breathlessness or wheezing.
- The usual dose is one inhalation twice a day, in the morning and evening, every day and not only when you have symptoms.
- Stop using it and get medical help straight away if you get tightness of the chest, coughing, wheezing or breathlessness immediately after using it, or signs of an allergic reaction.
- It is not for use in children or adolescents under 18 years.
- Use the inhaler within 90 days of opening the pouch.

## Who should not take aclidinium?
- If you are allergic to aclidinium bromide or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- If you have had heart problems recently
- If you see halos around lights or coloured images (glaucoma)
- If you have an enlarged prostate, problems passing urine, or a blockage in your bladder
- It is for maintenance treatment and should not be used to treat a sudden attack of breathlessness or wheezing
- If your COPD symptoms (breathlessness, wheezing, cough) do not improve or get worse, contact your doctor as soon as possible
- Dry mouth may be linked to tooth decay after long-term use, so pay attention to oral hygiene

## Side effects that need urgent help
- Allergic reactions (rare): swelling of your face, throat, lips or tongue (with or without difficulty breathing or swallowing), dizziness or fainting, faster heart rate, or raised severely itchy bumps on your skin (hives). Stop using the medicine and contact your doctor immediately
- Bronchospasm: tightness of the chest, coughing, wheezing or breathlessness immediately after using the medicine. Stop taking Eklira Genuair and seek medical help immediately (frequency not stated)

## How common are the side effects?
### Common (Up to 1 in 10 people)
- Headache
- Inflammation of the sinuses (sinusitis)
- Common cold (nasopharyngitis)
- Cough
- Diarrhoea
- Nausea

### Uncommon (Up to 1 in 100 people)
- Dizziness
- Dry mouth
- Inflammation of the mouth (stomatitis)
- Hoarseness (dysphonia)
- Faster heart beat (tachycardia)
- Sensation of heart beating (palpitations)
- Difficulty passing urine (urinary retention)
- Blurred vision
- Rash
- Itching of the skin

### Rare (Up to 1 in 1,000 people)
- Allergic reactions

## Other medicines the leaflet mentions
- Any other medicines you are taking, have recently taken or might take
- Similar medicines for breathing problems, such as medicines containing tiotropium or ipratropium (use together with Eklira Genuair is not recommended)

## Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use it while pregnant or breast-feeding unless your doctor tells you to.

## How to take it
- The recommended dose is one inhalation twice a day, in the morning and evening, ideally at the same times each day.
- Use it every day, not only when you have breathing problems; it is for long-term use, so talk to your doctor before stopping.
- It is inhaled using the Genuair inhaler; follow the Instructions for Use and ask your doctor or pharmacist if unsure. You can use it before or after food or drink.
- If you forget a dose, inhale it as soon as you remember, but skip it if it is nearly time for the next one. Do not take a double dose.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
